Browse by Audience
Chronic pain affects one-third of adults globally, leading to significant disability and healthcare costs. This review highlights the role of interpersonal processes in chronic pain adjustment, focusing on how partner […]
Learn More >Temporomandibular joint (TMJ) osteoarthritis with pain is a highly prevalent disorder affecting patients’ quality of life. A comprehensive understanding of cell type diversity and its dynamics in painful TMJ osteoarthritis […]
Learn More >This review critically examines psychosocial and behavioural interventions for chronic pain through an equity lens. We interrogate relevant literature drawing on three key organising principles; justice, access, and knowledge, to […]
Learn More >The objective of this research is to delve into the central pathological mechanisms involved in the transformation from acute to chronic pain.
Learn More >Atopic dermatitis (AD) is a chronic inflammatory skin condition, rising in prevalence and significantly impacting quality of life. Janus kinase (JAK) inhibitors are small molecules targeting the JAK-STAT signaling pathway, […]
Learn More >Opioid agonist treatment (OAT) is established for opioid use disorder, but limited data on adverse effects exist. We aimed to review relative risks of adverse effects across opioid agonists.
Learn More >Many rheumatoid arthritis (RA) patients continue to experience persistent pain even after successful management of joint inflammation. Clinical data indicate that RA patients treated with the JAK inhibitor baricitinib consistently […]
Learn More >Chronic pain is an impeding condition that affects day-to-day life and poses a substantial economic burden, surpassing many other health conditions. This study employs a cross-species integrated approach to uncover […]
Learn More >The fear of pain (FOP) and fear avoidance belief (FAB) play a crucial role in the occurrence and development of chronic pain. However, the dynamics of these factors in postsurgical […]
Learn More >We previously demonstrated that in a mouse line expressing a kappa opioid receptor (KOR) mutant with all the four phosphorylation sites mutated to alanines (K4A) the selective KOR agonist U50,488H […]
Learn More >